4.7 Review

Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging

Journal

NANOMEDICINE
Volume 1, Issue 2, Pages 209-217

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/17435889.1.2.209

Keywords

contrast agents; fluorescence; magnetic resonance imaging; nanoparticles; positron emission tomography; quantum dots; tumor imaging

Funding

  1. NCI NIH HHS [R01 CA108468, U54 CA119338, U54CA119338, R01 CA108468-01] Funding Source: Medline
  2. NIGMS NIH HHS [P20 GM072069] Funding Source: Medline

Ask authors/readers for more resources

Nanometer-sized particles, such as semiconductor quantum dots and iron oxide nanocrystals, have novel optical, electronic, magnetic or structural properties that are not available from either molecules or bulk solids. When linked with tumor-targeting ligands, such as monoclonal antibodies, peptide fragments of tumor-specific proteins or small molecules, these nanoparticles can be used to target tumor antigens (biomarkers) and tumor vasculatures with high affinity and specificity. In the mesoscopic size range of 5-100 nm diameter, quantum dots and related nanoparticles have large surface areas and functional groups that can be linked to multiple diagnostic (e.g., optical, radioisotopic or magnetic) and therapeutic (e.g., anticancer) agents. In this review, recent advances in the development and applications of bioconjugated quantum dots and multifunctional nanoparticles for in vivo tumor imaging and targeting are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available